Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Urological Cancer Therapeutics Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Urological Cancer Therapeutics Drugsmarket, defines the market attractiveness level of Urological Cancer Therapeutics Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Urological Cancer Therapeutics Drugs industry, describes the types of Urological Cancer Therapeutics Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Urological Cancer Therapeutics Drugs market and the development prospects and opportunities of Urological Cancer Therapeutics Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Urological Cancer Therapeutics Drugs market in Chapter 13.
By Player:
AstraZeneca
Astellas
Johnson & Johnson
Abbott Laboratories
Pfizer
Celgene Corporation
Indevus Pharmaceuticals Inc
Sanofi SA
Novartis
GlaxoSmithKline plc
Roche Healthcare
Ipsen
Dendreon Corporation
Ferring Pharmaceuticals
Bristol-Myers Squibb
By Type:
Xofigo
Jevtana
Inlyta
Votrient
Sutent
Zytiga
Xtandi
Opdivo
Provenge
By End-User:
Hospital
Medical Research Laboratory
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Urological Cancer Therapeutics Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Urological Cancer Therapeutics Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Urological Cancer Therapeutics Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Urological Cancer Therapeutics Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Urological Cancer Therapeutics Drugs Market Analysis and Outlook to 2022
-
7.1 Global Urological Cancer Therapeutics Drugs Consumption (2017-2022)
-
7.2 United States Urological Cancer Therapeutics Drugs Consumption (2017-2022)
-
7.3 Europe Urological Cancer Therapeutics Drugs Consumption (2017-2022)
-
7.4 China Urological Cancer Therapeutics Drugs Consumption (2017-2022)
-
7.5 Japan Urological Cancer Therapeutics Drugs Consumption (2017-2022)
-
7.6 India Urological Cancer Therapeutics Drugs Consumption (2017-2022)
-
7.7 South Korea Urological Cancer Therapeutics Drugs Consumption (2017-2022)
8 Region and Country-wise Urological Cancer Therapeutics Drugs Market Analysis and Outlook to 2028
-
8.1 Global Urological Cancer Therapeutics Drugs Consumption Forecast (2022-2028)
-
8.2 United States Urological Cancer Therapeutics Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Urological Cancer Therapeutics Drugs Consumption Forecast (2022-2028)
-
8.4 China Urological Cancer Therapeutics Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Urological Cancer Therapeutics Drugs Consumption Forecast (2022-2028)
-
8.6 India Urological Cancer Therapeutics Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Urological Cancer Therapeutics Drugs Consumption Forecast (2022-2028)
9 Global Urological Cancer Therapeutics Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Urological Cancer Therapeutics Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Xofigo Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Jevtana Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Inlyta Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Votrient Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Sutent Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Zytiga Consumption and Growth Rate (2017-2022)
-
9.1.7 Global Xtandi Consumption and Growth Rate (2017-2022)
-
9.1.8 Global Opdivo Consumption and Growth Rate (2017-2022)
-
9.1.9 Global Provenge Consumption and Growth Rate (2017-2022)
-
9.2 Global Urological Cancer Therapeutics Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Medical Research Laboratory Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Urological Cancer Therapeutics Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Urological Cancer Therapeutics Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Xofigo Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Jevtana Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Inlyta Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Votrient Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Sutent Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Zytiga Consumption Forecast and Growth Rate (2022-2028)
-
10.1.7 Global Xtandi Consumption Forecast and Growth Rate (2022-2028)
-
10.1.8 Global Opdivo Consumption Forecast and Growth Rate (2022-2028)
-
10.1.9 Global Provenge Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Urological Cancer Therapeutics Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Medical Research Laboratory Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Urological Cancer Therapeutics Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Urological Cancer Therapeutics Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Urological Cancer Therapeutics Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Urological Cancer Therapeutics Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Urological Cancer Therapeutics Drugs Market Competitive Analysis
-
14.1 AstraZeneca
-
14.1.1 AstraZeneca Company Details
-
14.1.2 AstraZeneca Urological Cancer Therapeutics Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 AstraZeneca Urological Cancer Therapeutics Drugs Product and Service
-
14.2 Astellas
-
14.2.1 Astellas Company Details
-
14.2.2 Astellas Urological Cancer Therapeutics Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Astellas Urological Cancer Therapeutics Drugs Product and Service
-
14.3 Johnson & Johnson
-
14.3.1 Johnson & Johnson Company Details
-
14.3.2 Johnson & Johnson Urological Cancer Therapeutics Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Johnson & Johnson Urological Cancer Therapeutics Drugs Product and Service
-
14.4 Abbott Laboratories
-
14.4.1 Abbott Laboratories Company Details
-
14.4.2 Abbott Laboratories Urological Cancer Therapeutics Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Abbott Laboratories Urological Cancer Therapeutics Drugs Product and Service
-
14.5 Pfizer
-
14.5.1 Pfizer Company Details
-
14.5.2 Pfizer Urological Cancer Therapeutics Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Pfizer Urological Cancer Therapeutics Drugs Product and Service
-
14.6 Celgene Corporation
-
14.6.1 Celgene Corporation Company Details
-
14.6.2 Celgene Corporation Urological Cancer Therapeutics Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Celgene Corporation Urological Cancer Therapeutics Drugs Product and Service
-
14.7 Indevus Pharmaceuticals Inc
-
14.7.1 Indevus Pharmaceuticals Inc Company Details
-
14.7.2 Indevus Pharmaceuticals Inc Urological Cancer Therapeutics Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Indevus Pharmaceuticals Inc Urological Cancer Therapeutics Drugs Product and Service
-
14.8 Sanofi SA
-
14.8.1 Sanofi SA Company Details
-
14.8.2 Sanofi SA Urological Cancer Therapeutics Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Sanofi SA Urological Cancer Therapeutics Drugs Product and Service
-
14.9 Novartis
-
14.9.1 Novartis Company Details
-
14.9.2 Novartis Urological Cancer Therapeutics Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Novartis Urological Cancer Therapeutics Drugs Product and Service
-
14.10 GlaxoSmithKline plc
-
14.10.1 GlaxoSmithKline plc Company Details
-
14.10.2 GlaxoSmithKline plc Urological Cancer Therapeutics Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 GlaxoSmithKline plc Urological Cancer Therapeutics Drugs Product and Service
-
14.11 Roche Healthcare
-
14.11.1 Roche Healthcare Company Details
-
14.11.2 Roche Healthcare Urological Cancer Therapeutics Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Roche Healthcare Urological Cancer Therapeutics Drugs Product and Service
-
14.12 Ipsen
-
14.12.1 Ipsen Company Details
-
14.12.2 Ipsen Urological Cancer Therapeutics Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Ipsen Urological Cancer Therapeutics Drugs Product and Service
-
14.13 Dendreon Corporation
-
14.13.1 Dendreon Corporation Company Details
-
14.13.2 Dendreon Corporation Urological Cancer Therapeutics Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Dendreon Corporation Urological Cancer Therapeutics Drugs Product and Service
-
14.14 Ferring Pharmaceuticals
-
14.14.1 Ferring Pharmaceuticals Company Details
-
14.14.2 Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Product and Service
-
14.15 Bristol-Myers Squibb
-
14.15.1 Bristol-Myers Squibb Company Details
-
14.15.2 Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.15.3 Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Urological Cancer Therapeutics Drugs
-
Figure Urological Cancer Therapeutics Drugs Picture
-
Table Global Urological Cancer Therapeutics Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Urological Cancer Therapeutics Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Urological Cancer Therapeutics Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Urological Cancer Therapeutics Drugs Consumption by Country (2017-2022)
-
Figure United States Urological Cancer Therapeutics Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Urological Cancer Therapeutics Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Urological Cancer Therapeutics Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Urological Cancer Therapeutics Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Urological Cancer Therapeutics Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Urological Cancer Therapeutics Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Urological Cancer Therapeutics Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Urological Cancer Therapeutics Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Urological Cancer Therapeutics Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Urological Cancer Therapeutics Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Urological Cancer Therapeutics Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Urological Cancer Therapeutics Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Urological Cancer Therapeutics Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Xofigo Consumption and Growth Rate (2017-2022)
-
Figure Global Jevtana Consumption and Growth Rate (2017-2022)
-
Figure Global Inlyta Consumption and Growth Rate (2017-2022)
-
Figure Global Votrient Consumption and Growth Rate (2017-2022)
-
Figure Global Sutent Consumption and Growth Rate (2017-2022)
-
Figure Global Zytiga Consumption and Growth Rate (2017-2022)
-
Figure Global Xtandi Consumption and Growth Rate (2017-2022)
-
Figure Global Opdivo Consumption and Growth Rate (2017-2022)
-
Figure Global Provenge Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Medical Research Laboratory Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Xofigo Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Jevtana Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Inlyta Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Votrient Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Sutent Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Zytiga Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Xtandi Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Opdivo Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Provenge Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Medical Research Laboratory Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Urological Cancer Therapeutics Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Urological Cancer Therapeutics Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Urological Cancer Therapeutics Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Urological Cancer Therapeutics Drugs Product and Service
-
Table Astellas (Foundation Year, Company Profile and etc.)
-
Table Astellas Urological Cancer Therapeutics Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astellas Urological Cancer Therapeutics Drugs Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Urological Cancer Therapeutics Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Urological Cancer Therapeutics Drugs Product and Service
-
Table Abbott Laboratories (Foundation Year, Company Profile and etc.)
-
Table Abbott Laboratories Urological Cancer Therapeutics Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Laboratories Urological Cancer Therapeutics Drugs Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Urological Cancer Therapeutics Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Urological Cancer Therapeutics Drugs Product and Service
-
Table Celgene Corporation (Foundation Year, Company Profile and etc.)
-
Table Celgene Corporation Urological Cancer Therapeutics Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celgene Corporation Urological Cancer Therapeutics Drugs Product and Service
-
Table Indevus Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)
-
Table Indevus Pharmaceuticals Inc Urological Cancer Therapeutics Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Indevus Pharmaceuticals Inc Urological Cancer Therapeutics Drugs Product and Service
-
Table Sanofi SA (Foundation Year, Company Profile and etc.)
-
Table Sanofi SA Urological Cancer Therapeutics Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi SA Urological Cancer Therapeutics Drugs Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Urological Cancer Therapeutics Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Urological Cancer Therapeutics Drugs Product and Service
-
Table GlaxoSmithKline plc (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline plc Urological Cancer Therapeutics Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline plc Urological Cancer Therapeutics Drugs Product and Service
-
Table Roche Healthcare (Foundation Year, Company Profile and etc.)
-
Table Roche Healthcare Urological Cancer Therapeutics Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Healthcare Urological Cancer Therapeutics Drugs Product and Service
-
Table Ipsen (Foundation Year, Company Profile and etc.)
-
Table Ipsen Urological Cancer Therapeutics Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ipsen Urological Cancer Therapeutics Drugs Product and Service
-
Table Dendreon Corporation (Foundation Year, Company Profile and etc.)
-
Table Dendreon Corporation Urological Cancer Therapeutics Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dendreon Corporation Urological Cancer Therapeutics Drugs Product and Service
-
Table Ferring Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Product and Service
-
